Logan, A., Yalniz, F., Zhang, A., Miller, K., Sutherland, K., Jeyakumar, N., … Muffly, L. (2025). Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world. In Blood (Vol. 146, pp. 516–516). American Society of Hematology. https://doi.org/10.1182/blood-2025-516

Logan, Aaron, Fevzi Yalniz, Amy Zhang, Katharine Miller, Katherine Sutherland, Nikeshan Jeyakumar, Hrishikesh Srinagesh, et al. “Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world.” In Blood, 146:516–516. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-516.

Logan A, Yalniz F, Zhang A, Miller K, Sutherland K, Jeyakumar N, et al. Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world. In: Blood. American Society of Hematology; 2025. p. 516–516.

Logan, Aaron, et al. “Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 516–516. Crossref, doi:10.1182/blood-2025-516.

Logan A, Yalniz F, Zhang A, Miller K, Sutherland K, Jeyakumar N, Srinagesh H, Grunwald M, Kota V, Boccucci J, Ulrickson M, Al-Darobi A, Sasine J, Hill L, Muhsen I, Advani A, Aldoss I, Othman T, Sandhu K, Reshef R, Luskin M, Chen E, Lin C, Cassaday R, Kopmar N, Solh M, Lee C, Odstrcil Bobillo S, Tsai S, O’Connor T, Hilal T, Park J, Valtis Y, Vasu S, Bezerra E, Wang E, Leonard J, Tan V, O’Dwyer K, Moore J, McCauley R, Majhail N, Mountjoy L, Ramakrishnan A, Malik S, Battiwalla M, Shaughnessy P, Mathews J, Jamy O, Mohty R, Kumaran M, Hoeg R, Stock W, Roloff G, Oliai C, Lill G, Schwartz M, Koura D, Dykes K, Daunov M, Byrd K, Bachanova V, Tracy S, Grover P, Frey N, Connor M, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole O, Dholaria B, Faramand R, Muffly L. Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world. Blood. American Society of Hematology; 2025. p. 516–516.